Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

NUT rearrangement is uncommon in human thymic epithelial tumors.

Petrini P, French CA, Rajan A, Cameron MJ, Jaffe ES, Zucali PA, Xie J, Wang Y, Giaccone G.

J Thorac Oncol. 2012 Apr;7(4):744-50. doi: 10.1097/JTO.0b013e3182460f8f.

2.

[Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].

Fang W, French CA, Cameron MJ, Han YD, Liu HG.

Zhonghua Bing Li Xue Za Zhi. 2012 Aug;41(8):519-24. doi: 10.3760/cma.j.issn.0529-5807.2012.08.003. Chinese.

PMID:
23157742
3.

NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract.

Stelow EB, Bellizzi AM, Taneja K, Mills SE, Legallo RD, Kutok JL, Aster JC, French CA.

Am J Surg Pathol. 2008 Jun;32(6):828-34. doi: 10.1097/PAS.0b013e31815a3900.

PMID:
18391746
4.

Pathologic characteristics of NUT midline carcinoma arising in the mediastinum.

Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM.

Am J Surg Pathol. 2012 Aug;36(8):1222-7. doi: 10.1097/PAS.0b013e318258f03b.

5.

Nuclear protein in testis midline carcinomas: a lethal and underrecognized entity.

Davis BN, Karabakhtsian RG, Pettigrew AL, Arnold SM, French CA, Brill YM.

Arch Pathol Lab Med. 2011 Nov;135(11):1494-8. doi: 10.5858/arpa.2010-0389-CR.

PMID:
22032580
6.

Demystified molecular pathology of NUT midline carcinomas.

French CA.

J Clin Pathol. 2010 Jun;63(6):492-6. doi: 10.1136/jcp.2007.052902. Epub 2008 Jun 13. Review.

PMID:
18552174
7.

Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract.

Fang W, French CA, Cameron MJ, Han Y, Liu H.

Int J Surg Pathol. 2013 Apr;21(2):102-10. doi: 10.1177/1066896912451651. Epub 2012 Jul 9.

PMID:
22777717
8.

NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland.

Ziai J, French CA, Zambrano E.

Head Neck Pathol. 2010 Jun;4(2):163-8. doi: 10.1007/s12105-010-0174-6. Epub 2010 Mar 30.

9.

NUT midline carcinomas in the thymic region.

Gökmen-Polar Y, Cano OD, Kesler KA, Loehrer PJ, Badve S.

Mod Pathol. 2014 Dec;27(12):1649-56. doi: 10.1038/modpathol.2014.63. Epub 2014 May 23.

10.

Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.

Thompson-Wicking K, Francis RW, Stirnweiss A, Ferrari E, Welch MD, Baker E, Murch AR, Gout AM, Carter KW, Charles AK, Phillips MB, Kees UR, Beesley AH.

Oncogene. 2013 Sep 26;32(39):4664-74. doi: 10.1038/onc.2012.487. Epub 2012 Nov 5.

PMID:
23128391
11.

Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).

Tiseo M, Damato A, Longo L, Barbieri F, Bertolini F, Stefani A, Migaldi M, Gnetti L, Camisa R, Bordi P, Buti S, Rossi G.

Lung Cancer. 2017 Feb;104:24-30. doi: 10.1016/j.lungcan.2016.12.005. Epub 2016 Dec 14.

PMID:
28212996
12.

Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.

Ma Y, Li Q, Cui W, Miao N, Liu X, Zhang W, Zhang C, Wang J.

Diagn Pathol. 2012 Sep 14;7:120. doi: 10.1186/1746-1596-7-120.

13.

BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.

French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA.

Cancer Res. 2003 Jan 15;63(2):304-7.

14.

Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center.

Okuma Y, Hosomi Y, Watanabe K, Yamada Y, Horio H, Maeda Y, Okamura T, Hishima T.

BMC Cancer. 2014 May 20;14:349. doi: 10.1186/1471-2407-14-349.

15.

Diffuse high intensity PD-L1 staining in thymic epithelial tumors.

Padda SK, Riess JW, Schwartz EJ, Tian L, Kohrt HE, Neal JW, West RB, Wakelee HA.

J Thorac Oncol. 2015 Mar;10(3):500-8. doi: 10.1097/JTO.0000000000000429.

16.

Midline carcinoma of children and young adults with NUT rearrangement.

French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, Miyoshi I, Perez-Atayde AR, Aster JC, Fletcher JA.

J Clin Oncol. 2004 Oct 15;22(20):4135-9.

PMID:
15483023
17.

Carcinomas of the upper aerodigestive tract with rearrangement of the nuclear protein of the testis (NUT) gene (NUT midline carcinomas).

Stelow EB, French CA.

Adv Anat Pathol. 2009 Mar;16(2):92-6. doi: 10.1097/PAP.0b013e31819923e4. Review.

PMID:
19550370
18.

Imatinib mesylate in thymic epithelial malignancies.

Palmieri G, Marino M, Buonerba C, Federico P, Conti S, Milella M, Petillo L, Evoli A, Lalle M, Ceribelli A, Merola G, Matano E, Sioletic S, De Placido S, Di Lorenzo G, Damiano V.

Cancer Chemother Pharmacol. 2012 Feb;69(2):309-15. doi: 10.1007/s00280-011-1690-0. Epub 2011 Jun 28.

PMID:
21710245
19.

Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody.

Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, Chang MC, Aster JC, French CA.

Am J Surg Pathol. 2009 Jul;33(7):984-91. doi: 10.1097/PAS.0b013e318198d666.

20.

p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study.

Tateyama H, Eimoto T, Tada T, Mizuno T, Inagaki H, Hata A, Sasaki M, Masaoka A.

Am J Clin Pathol. 1995 Oct;104(4):375-81.

PMID:
7572785

Supplemental Content

Support Center